nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycrimine—CHRM1—Monoamine GPCRs—ADRA1D—polycystic ovary syndrome	0.0464	0.0464	CbGpPWpGaD
Cycrimine—CHRM1—Monoamine GPCRs—ADRA1B—polycystic ovary syndrome	0.0451	0.0451	CbGpPWpGaD
Cycrimine—CHRM1—Amine ligand-binding receptors—ADRA1D—polycystic ovary syndrome	0.039	0.039	CbGpPWpGaD
Cycrimine—CHRM1—Amine ligand-binding receptors—ADRA1B—polycystic ovary syndrome	0.0379	0.0379	CbGpPWpGaD
Cycrimine—CHRM1—Monoamine GPCRs—ADRA1A—polycystic ovary syndrome	0.0342	0.0342	CbGpPWpGaD
Cycrimine—CHRM1—Monoamine GPCRs—ADRB3—polycystic ovary syndrome	0.0329	0.0329	CbGpPWpGaD
Cycrimine—CHRM1—Amine ligand-binding receptors—ADRA1A—polycystic ovary syndrome	0.0287	0.0287	CbGpPWpGaD
Cycrimine—CHRM1—Amine ligand-binding receptors—ADRB3—polycystic ovary syndrome	0.0277	0.0277	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—SFTPC—polycystic ovary syndrome	0.0238	0.0238	CbGpPWpGaD
Cycrimine—CHRM1—Monoamine GPCRs—ADRB2—polycystic ovary syndrome	0.0178	0.0178	CbGpPWpGaD
Cycrimine—CHRM1—Amine ligand-binding receptors—ADRB2—polycystic ovary syndrome	0.0149	0.0149	CbGpPWpGaD
Cycrimine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.0139	0.0139	CbGpPWpGaD
Cycrimine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.0135	0.0135	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.0125	0.0125	CbGpPWpGaD
Cycrimine—CHRM1—G alpha (q) signalling events—PTAFR—polycystic ovary syndrome	0.0119	0.0119	CbGpPWpGaD
Cycrimine—CHRM1—G alpha (q) signalling events—ADRA1D—polycystic ovary syndrome	0.0116	0.0116	CbGpPWpGaD
Cycrimine—CHRM1—G alpha (q) signalling events—ADRA1B—polycystic ovary syndrome	0.0113	0.0113	CbGpPWpGaD
Cycrimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTAFR—polycystic ovary syndrome	0.0107	0.0107	CbGpPWpGaD
Cycrimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1D—polycystic ovary syndrome	0.0104	0.0104	CbGpPWpGaD
Cycrimine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRA1A—polycystic ovary syndrome	0.0102	0.0102	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.0101	0.0101	CbGpPWpGaD
Cycrimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.0101	0.0101	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.00989	0.00989	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.00986	0.00986	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.00986	0.00986	CbGpPWpGaD
Cycrimine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.00986	0.00986	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00922	0.00922	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00895	0.00895	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00871	0.00871	CbGpPWpGaD
Cycrimine—CHRM1—Regulation of Actin Cytoskeleton—FGF18—polycystic ovary syndrome	0.00856	0.00856	CbGpPWpGaD
Cycrimine—CHRM1—G alpha (q) signalling events—ADRA1A—polycystic ovary syndrome	0.00854	0.00854	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00845	0.00845	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00845	0.00845	CbGpPWpGaD
Cycrimine—CHRM1—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.00794	0.00794	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.0079	0.0079	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00771	0.00771	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00767	0.00767	CbGpPWpGaD
Cycrimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.00764	0.00764	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00746	0.00746	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00722	0.00722	CbGpPWpGaD
Cycrimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.0071	0.0071	CbGpPWpGaD
Cycrimine—CHRM1—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.0071	0.0071	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.00685	0.00685	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.0066	0.0066	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00643	0.00643	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00643	0.00643	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00635	0.00635	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00618	0.00618	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00602	0.00602	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00599	0.00599	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00584	0.00584	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00568	0.00568	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00565	0.00565	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00561	0.00561	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00544	0.00544	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00544	0.00544	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00538	0.00538	CbGpPWpGaD
Cycrimine—CHRM1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00536	0.00536	CbGpPWpGaD
Cycrimine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00532	0.00532	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00526	0.00526	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00506	0.00506	CbGpPWpGaD
Cycrimine—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00494	0.00494	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.0049	0.0049	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00481	0.00481	CbGpPWpGaD
Cycrimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.0048	0.0048	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00476	0.00476	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00471	0.00471	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00446	0.00446	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00436	0.00436	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00431	0.00431	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00415	0.00415	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.0041	0.0041	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.004	0.004	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00396	0.00396	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00394	0.00394	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00386	0.00386	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00386	0.00386	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00384	0.00384	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.0037	0.0037	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00366	0.00366	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00364	0.00364	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00364	0.00364	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00358	0.00358	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00355	0.00355	CbGpPWpGaD
Cycrimine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00343	0.00343	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.0034	0.0034	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.0033	0.0033	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.0033	0.0033	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.0033	0.0033	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00321	0.00321	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00309	0.00309	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00304	0.00304	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.003	0.003	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00294	0.00294	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00292	0.00292	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00292	0.00292	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.0027	0.0027	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00267	0.00267	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00266	0.00266	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00265	0.00265	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00265	0.00265	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00243	0.00243	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00242	0.00242	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.00239	0.00239	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00234	0.00234	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00234	0.00234	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00231	0.00231	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00226	0.00226	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00224	0.00224	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00221	0.00221	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00217	0.00217	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00213	0.00213	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00211	0.00211	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.0021	0.0021	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00208	0.00208	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00207	0.00207	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00205	0.00205	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00197	0.00197	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00195	0.00195	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00195	0.00195	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00188	0.00188	CbGpPWpGaD
Cycrimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00184	0.00184	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00182	0.00182	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00177	0.00177	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00172	0.00172	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00168	0.00168	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00157	0.00157	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00153	0.00153	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00143	0.00143	CbGpPWpGaD
Cycrimine—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.0014	0.0014	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00139	0.00139	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00134	0.00134	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00131	0.00131	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.00127	0.00127	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00126	0.00126	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00126	0.00126	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.00124	0.00124	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00121	0.00121	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00118	0.00118	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00117	0.00117	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00116	0.00116	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00115	0.00115	CbGpPWpGaD
Cycrimine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.00114	0.00114	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00111	0.00111	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00109	0.00109	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00108	0.00108	CbGpPWpGaD
Cycrimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00108	0.00108	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00107	0.00107	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00101	0.00101	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000996	0.000996	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000952	0.000952	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000905	0.000905	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000891	0.000891	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000882	0.000882	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00082	0.00082	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00082	0.00082	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00079	0.00079	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000782	0.000782	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000763	0.000763	CbGpPWpGaD
Cycrimine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000759	0.000759	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000722	0.000722	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000717	0.000717	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000715	0.000715	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000689	0.000689	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000679	0.000679	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000629	0.000629	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000599	0.000599	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000588	0.000588	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000504	0.000504	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000493	0.000493	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00044	0.00044	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000424	0.000424	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000421	0.000421	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000408	0.000408	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000407	0.000407	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000387	0.000387	CbGpPWpGaD
Cycrimine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000312	0.000312	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000266	0.000266	CbGpPWpGaD
Cycrimine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	0.000184	0.000184	CbGpPWpGaD
